(Q50968651)

26 March 2018

title

Clinical, endocrine, and metabolic effects of two doses of gestrinone in treatment of pelvic endometriosis. (English)

1 reference

26 March 2018

1 reference

Dawood MY

1

1 reference

26 March 2018

Obasiolu CW

series ordinal

2

1 reference

26 March 2018

Ramos J

series ordinal

3

1 reference

26 March 2018

Khan-Dawood FS

series ordinal

4

1 reference

26 March 2018

language of work or name

English

0 references

publication date

1 February 1997

1 reference

26 March 2018

American Journal of Obstetrics and Gynecology

published in

1 reference

26 March 2018

volume

176

1 reference

26 March 2018

issue

2

1 reference

26 March 2018

page(s)

387-394

1 reference

26 March 2018

A new approach to estrogen-free contraception based on progesterone receptor blockage by mid-cycle administration of ethyl norgestrienone (R 2323)

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2897%2970504-0

Contraception with long acting subdermal implants: II. Measured and perceived effects in international clinical trials

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2897%2970504-0

Treatment of endometriosis with gestrinone (R-2323), a synthetic antiestrogen, antiprogesterone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2897%2970504-0

The morphologic effect of short-term medical therapy of endometriosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2897%2970504-0

Gestrinone versus danazol in the treatment of endometriosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2897%2970504-0

Endocrine, metabolic, and clinical effects of gestrinone in women with endometriosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2897%2970504-0

A randomized double-blind prospective trial of two doses of gestrinone in the treatment of endometriosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2897%2970504-0

Revised American Fertility Society classification of endometriosis: 1985

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2897%2970504-0

Human ovarian oxytocin: its source and relationship to steroid hormones

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2897%2970504-0

The Effect of Naloxone on Endogenous Opioid Regulation of Pituitary Gonadotropins and Prolactin during the Menstrual Cycle*

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2897%2970504-0

Cortical and trabecular bone mineral content in women with endometriosis: effect of gonadotropin-releasing hormone agonist and danazol

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2897%2970504-0

A randomized comparative study of the metabolic effects of two regimens of gestrinone in the treatment of endometriosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2897%2970504-0

Effect of gestrinone in endometriosis tissue and endometrium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2897%2970504-0

A comparison of the effects of danazol and gestrinone on testosterone binding to sex hormone binding globulin in vitro and in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2897%2970504-0

The effects of a once-a-week steroid contraceptive (R2323) on lipid and carbohydrate metabolism in women during three months of use

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2897%2970504-0

Transport of steroid hormones: interaction of 70 drugs with testosterone-binding globulin and corticosteroid-binding globulin in human plasma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2897%2970504-0

Depot leuprolide acetate versus danazol for treatment of pelvic endometriosis: changes in vertebral bone mass and serum estradiol and calcitonin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2897%2970504-0

Impact of medical treatment of endometriosis on bone mass

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2897%2970504-0

Impact of gestrinone on the course of asymptomatic endometriosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2897%2970504-0

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0002-9378(97)70504-0

1 reference

26 March 2018

PubMed ID

9065187

1 reference

26 March 2018